NTAP is joining ADAI

Department News | January 28, 2026

Earlier this month, the Center for Novel Therapeutics in Addiction Psychiatry (NTAP) joined the Addictions, Drug & Alcohol Institute (ADAI).








Researchers pinpoint biomarkers for schizophrenia 

UW Medicine Newsroom | January 20, 2026

Two biomarkers — verbal learning and identifying other peoples’ emotions — could distinguish between people with and without schizophrenia “The fact that we only needed two tests was really quite shocking,” said Robert Chen, MD, PhD.